Akumin Inc. Launches Exchange Offer and Consent Solicitation
Akumin Inc. has embarked on a significant initiative to offer Eligible Holders an opportunity to exchange their outstanding senior secured notes for newly issued notes that aim to enhance the company's liquidity and financial stability.
Details of the Exchange Offer
The company is reaching out to eligible participants to exchange any and all of its existing senior secured notes for 9.750% Senior Secured Notes due 2031. This strategic move introduces a favorable interest rate, potentially decreasing to 8.750% under certain conditions, thus allowing Akumin to offer attractive new investment opportunities amid fluctuating market conditions.
Interest Rate Adjustments and Guarantees
The interest on the new notes could lessen to an appealing rate if specific ratings are achieved from recognized rating agencies. The new notes are backed by numerous wholly-owned subsidiaries and select affiliates, providing a robust safety net for investors.
Consent Solicitation to Simplify Governance
In tandem with the exchange offer, Akumin is soliciting consents from eligible holders to amend the terms of the existing notes. This is set to eliminate restrictive covenants that currently govern the old notes, thereby providing more flexibility as the company navigates future growth.
Support Agreement with Key Stakeholders
Akumin has successfully secured a Support Agreement with notable noteholders, representing over 95% of the outstanding notes. This strategic alignment aims to reduce overall debt and maximize liquidity. Among the supporters is the investment firm Stonepeak, which is committed to injecting approximately $154.5 million to bolster growth opportunities for Akumin.
Investment Opportunities
The table of exchange considerations specifies that each participant who tenders their old notes by the Early Deadline will receive a total consideration amounting to $1.00 per principal amount of notes. For those tendering after the early deadline, the consideration decreases to $0.95.
Completion Timeline for Transactions
The company is laying out a clear timeline for all participants, with the exchange offer set to close at 5:00 PM, New York City time, on a specified date. This deadline emphasizes the urgency and importance for holders to consider their participation in this strategic exchange.
Akumin’s Commitment to Growth and Innovation
Akumin is not just focused on financial maneuvering; its core mission remains patient-centered care. As a leading provider of advanced imaging and radiation oncology services, the company is committed to enhancing access to critical diagnostic services for its patients. By partnering with an extensive network of hospitals and physician groups, Akumin integrates operational excellence with innovative technology.
Expanding Community and Patient Care
Through its innovative Akumin AXIS Expandable Patient Solutions™, the company is capable of reaching more individuals in need of imaging services. This focus on accessibility and quality care is a testament to Akumin's commitment to community welfare.
Frequently Asked Questions
What is the purpose of Akumin's exchange offer?
The exchange offer aims to exchange outstanding senior secured notes for new notes, enhancing liquidity and reducing debt.
What benefits do the new notes offer?
The new notes come with an initial interest rate of 9.750% that may decrease to 8.750% based on certain conditions.
Who are the supporting stakeholders in this initiative?
Key stakeholders include noteholders representing over 95% of the outstanding notes and the investment firm Stonepeak.
How does the consent solicitation work?
The consent solicitation asks eligible holders to agree to amend terms on existing notes, which would ease certain restrictive covenants.
What role does Akumin's new investment play?
The $154.5 million investment is intended to support Akumin's long-term growth, focusing on expanding its service offerings.
